Actavis gets green light for generic Keppra XR, launches product
MORRISTOWN, N.J. — Actavis has launched its version of an epilepsy drug made by UCB.
The generic drug maker said it received approval from the Food and Drug Administration for levetiracetam extended-release tablets and commenced shipping the product following approval. The drug is the generic equivalent of Keppra XR.
U.S. sales of Keppra XR were about $161 million for the 12 months ended June 30, according IMS Health data.
No comments found
Kevin Wingerter joins Fera
NEW YORK — Fera Pharmaceuticals has appointed a new director of national accounts.
The drug maker said that Kevin Wingerter, who most recently served as senior buyer of pharmaceutical merchandising at Walmart, has joined the company. Wingerter brings more than 20 years of experience in procurement of both branded and generic pharmaceuticals, Fera said.
“As Fera continues to expand its offering in generic pharmaceuticals, Kevin’s role and expertise are critical to our managing our business effectively and providing the customer service Fera insists upon” Fera VP sales Craig Salmon said.
No comments found
Rite Aid offers ‘virtual’ clinics
CAMP HILL, Pa. — Rite Aid is teaming up with OptumHealth to become the first to provide "virtual clinics" in a retail pharmacy setting.
Rite Aid announced Thursday the launch of NowClinic online care services at select Rite Aid stores in the Detroit area. NowClinic allows Rite Aid customers to interact in real time with doctors and OptumHealth nurses.
Customers will be able to use the Internet to have private consultations with doctors about symptoms, as well as obtaining guidance, diagnoses and prescriptions for certain medications. They also can have conversations with nurses, who can provide basic healthcare education, information on common medical problems and identification of appropriate provider options for care. Customers can obtain a record of each interaction to share with a primary care provider.
That kind of leadership and innovation one would expect from Optum but not necessarily from Rite Aid. Is this a technology precursor of a potential Walmart acquisition?